about the rheumatologist

Dr. Lui is a specialist Rheumatologist committed to delivering compassionate, patientcentred care for both general and complex autoimmune conditions. He is highly regarded for his expertise in early diagnosis, precision treatment, and advanced therapeutics, with particular clinical focus in Spondyloarthritis, Rheumatoid Arthritis, and Systemic Lupus Erythematosus.

🎓 Training & Professional Accreditation

Dr Lui graduated from the National University of Singapore (NUS) Faculty of Medicine in 2001. He subsequently obtained his Master of Medicine in Internal Medicine and became a Member of the Royal College of Physicians (UK) in 2006. He achieved specialist accreditation in Rheumatology in Singapore in 2009 and was later elected:

  • Fellow, Academy of Medicine Singapore (2012)
  • Fellow, Royal College of Physicians of Edinburgh (2015)

🏥 Clinical Leadership & Contributions

Before entering private practice, Dr Lui served as Consultant Rheumatologist at the Autoimmunity and Rheumatology Centre, Singapore General Hospital (SGH), where he helped with the formation and running of the sub-specialty clinics in Spondyloarthritis and SLE.

In 2009, he was awarded the prestigious SingHealth Health Manpower Development Plan (HMDP) fellowship, training at Toronto Western Hospital, University of Toronto, in Ankylosing Spondylitis. Upon returning to SGH, he established the clinical and research frameworks that shaped SGH’s dedicated Spondyloarthritis service.

📚 Academic Roles & Medical Education

A passionate educator, Dr Lui played a key role in shaping rheumatology training in Singapore. He served as:

  • Program Director, ACGMEI Rheumatology Senior Residency
  • Departmental Director of Postgraduate Education
  • Adjunct Assistant Professor, DukeNUS Medical School
  • Clinical Senior Lecturer, Yong Loo Lin School of Medicine, NUS

🔬 Research & Publications

Dr Lui has published extensively in international peerreviewed journals and served as a reviewer for global rheumatology publications. He was:

  • Principal Investigator, MEASURE2 Phase 3 Trial (Secukinumab for Ankylosing Spondylitis)
  • CoInvestigator, FUTURE2 Phase 3 Trial (Secukinumab for Psoriatic Arthritis)

 

These landmark studies contributed to the global advancement of biologic therapies in rheumatology.

⭐ Awards & Recognition

His dedication to patient care and medical education has been honoured through multiple national and institutional awards, including:

  • National Excellent Service Award (Silver) – 2008
  • SGH Service with a Heart Awards – 2008, 2011, 2012, 2013
  • Singapore Health Quality Service Award (Silver) – 2010
  • Singapore Health Quality Service Award (Star) – 2013
  • RISE Award for Outstanding Faculty – 2014